Resalis Therapeutics today announced the dosing of the first participant in a Phase 1b clinical study of its lead candidate, RES-010, a novel antisense oligonucleotide targeting microRNA-22 (miR-22), ...
Patient enrollment has been completed; all enrolled patients remain alive Data presented at the Nuclear Medicine and Neuro-Oncology (NMN) Society Annual Symposium The investigator-initiated Phase 1 ...
America's largest healthcare educator, and Advocate Health, the third-largest nonprofit integrated health system in the U.S., today announced a new collaboration to expand access to nursing education ...
On June 24, James Law, President of the International Solid Waste Association (ISWA), visited SUS ENVIRONMENT's Shanghai ...
Sermatec made a strong appearance at Intersolar Europe 2026, presenting its comprehensive portfolio of energy storage products and intelligent energy management solutions. Demonstrating capabilities ...
Aplagon, a clinical-stage biotechnology company developing APAC, a first-in-class antiplatelet and anticoagulant therapeutic platform for thrombo-inflammatory diseases, today announced the appointment ...
The industry forum "5G-A Experience Monetization: Terminal-Network-Business Synergy" concluded in Shanghai. Industry leaders ...
An upcoming educational broadcasting segment unpacks the growing logistical friction in American fuel manufacturing and the ...
Company intends to opportunistically acquire SpaceX shares as a long-term strategic treasury holding, reflecting alignment with the next era of aerospace, energy, and transportation infrastructure ...
Backed by strong client evaluations, EPAM's #1 rankings in general satisfaction, application services and service delivery ...
The Annual General Meeting of Minesto AB, held 23 June 2026, resolved to elect Philippe Kavafyan as a new member of the Board of Directors. With more than 30 years of experience in the international ...
Trusted by leading brands, PR Newswire Amplify™ extends its distribution strengths as the company pioneers intelligent, ...